BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li L, Huang YH, Li Y, Wang FQ, Shang BY, Zhen YS. Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma. World J Gastroenterol 2005; 11(29): 4478-4483 [PMID: 16052675 DOI: 10.3748/wjg.v11.i29.4478]
URL: https://www.wjgnet.com/1007-9327/full/v11/i29/4478.htm
Number Citing Articles
1
Yanqing Wen, Shuzhen Chen, Zhiyun Meng, Hui Gan, Xiaoxia Zhu, Zhuona Wu, Ruolan Gu, GuiFang Dou. Simultaneous determination of lidamycin enediyne chromophore (LDC) and its aromatized derivative (LDCA) using puerarin as internal standard in rat plasma by LC‐MS/MSBiomedical Chromatography 2012; 26(3): 400 doi: 10.1002/bmc.1676
2
Genshen Zhong, Shenghua Zhang, Yi Li, Xiujun Liu, Ruijuan Gao, Qingfang Miao, Yongsu Zhen. A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic miceCancer Letters 2010; 295(1): 124 doi: 10.1016/j.canlet.2010.02.020
3
Lei Hu, ShengHua Zhang, RongGuang Shao, YongSu Zhen. Lidamycin inhibits tumor growth and pulmonary metastasis in murine breast carcinoma and shows synergy with paclitaxelChinese Science Bulletin 2013; 58(23): 2805 doi: 10.1007/s11434-013-5732-3
4
Ruijuan Gao, Liang Li, Boyang Shang, Chunyan Zhao, Weijin Sheng, Diandong Li. A Gelatinases‐targeting scFv‐based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against HepatomaBasic & Clinical Pharmacology & Toxicology 2015; 117(2): 105 doi: 10.1111/bcpt.12379
5
Ajeeth Adhikari, Christiana N. Teijaro, Craig A. Townsend, Ben Shen. Comprehensive Natural Products III2020; : 365 doi: 10.1016/B978-0-12-409547-2.14651-7
6
Ziqiang Liu, Jiacheng Lai, Heng Jiang, Chengyuan Ma, Haiyan Huang. Collagen XI alpha 1 chain, a potential therapeutic target for cancerThe FASEB Journal 2021; 35(6) doi: 10.1096/fj.202100054RR
7
Yong-Hong Huang, Yun-Fei Cao, Zhi-Yuan Jiang, Sen Zhang, Feng Gao. Th22 cell accumulation is associated with colorectal cancer developmentWorld Journal of Gastroenterology 2015; 21(14): 4216-4224 doi: 10.3748/wjg.v21.i14.4216
8
Mulan Wei, Xujie Liu, Chunyu Cao, Jianlin Yang, Yafeng Lv, Jiaojiao Huang, Yanlin Wang, Ye Qin. An engineered PD-1-based and MMP-2/9-oriented fusion protein exerts potent antitumor effects against melanomaBMB Reports 2018; 51(11): 572 doi: 10.5483/BMBRep.2018.51.11.076
9
Ajeeth Adhikari, Ben Shen, Christoph Rader. Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugatesAntibody Therapeutics 2021; 4(1): 1 doi: 10.1093/abt/tbab001
10
Qing-fang Miao, Xiao-yun Liu, Bo-yang Shang, Zhi-gang Ouyang, Yong-su Zhen. An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activityAnti-Cancer Drugs 2007; 18(2): 127 doi: 10.1097/CAD.0b013e3280112779
11
QingFang Miao, BoYang Shang, ZhiGang Ouyang, XiaoYun Liu, YongSu Zhen. Generation and antitumor effects of an engineered and energized fusion protein VL-LDP-AE composed of single-domain antibody and lidamycinScience in China Series C: Life Sciences 2007; 50(4): 447 doi: 10.1007/s11427-007-0058-5
12
DENG KONG, XIAOKE WANG, XIAOHONG WANG, XUEYUN WANG, XIAOLI CHEN, GUOQIANG JI, XINHUA FU, SHOUXUN WANG. Design, expression and characterization of single chain Fv, Mms13 and the single chain Fv-mms13 fusion proteinMolecular Medicine Reports 2015; 12(1): 1213 doi: 10.3892/mmr.2015.3561
13
Rong-guang Shao, Yong-su Zhen. Recent Advances in Cancer Research and Therapy2012; : 153 doi: 10.1016/B978-0-12-397833-2.00007-8
14
Bowen Liu, Jun Liu, Yang Qiu, Jiao Chen, Jing Yang. MITA Promotes Macrophage Proinflammatory Polarization and Its circRNA-Related Regulatory Mechanism in Recurrent MiscarriageInternational Journal of Molecular Sciences 2023; 24(11): 9545 doi: 10.3390/ijms24119545